1743 studies found for:    "Ovarian Neoplasms"
Show Display Options
Rank Status Study
21 Completed Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
Conditions: Ovarian Neoplasms;   Breast Neoplasms
Intervention:
22 Completed STELLA Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer
Conditions: Endometrial Neoplasms;   Ovarian Neoplasms
Interventions: Procedure: Transperitoneal laparoscopic aortic lymphadenectomy;   Procedure: Extraperitoneal laparoscopic aortic lymphadenectomy
23 Terminated Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer
Conditions: Ovarian Cancer;   Epithelial Ovarian Cancer;   Fallopian Tube Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Drug: Lenalidomide, Liposomal Doxorubicin, Bevacizumab;   Drug: Revlimid, Doxil, Avastin
24 Recruiting MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer
Conditions: Cancer of Ovary;   Cancer of the Ovary;   Neoplasms, Ovarian;   Ovarian Cancer;   Ovary Cancer;   Ovary Neoplasms
Interventions: Device: MRI-guided SBRT;   Behavioral: EORTC QLQ-C30 Questionnaire;   Behavioral: EORTC QLQ-OV28 Questionnaire
25 Terminated Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases;   Ovarian Neoplasms
Interventions: Other: Laboratory Tumor Marker Analysis;   Other: Transvaginal Ultrasound;   Other: Health Status Questionnaire
26 Recruiting Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment
Conditions: Recurrent Ovarian Cancer;   Platinum Sensitive Ovarian Cancer
Intervention: Drug: Carboplatin
27 Completed DOXIL for Consolidation Therapy in Ovarian Cancer.
Condition: Ovarian Neoplasm
Intervention: Drug: liposomal doxorubicin
28 Active, not recruiting Lymphadenectomy In Ovarian Neoplasms
Condition: Ovarian Cancer
Interventions: Procedure: No Lymphadenectomy (LNE);   Procedure: Lymphadenectomy (LNE)
29 Completed A Study of Trabectedin in Patients With Advanced Ovarian Cancer
Conditions: Ovarian Neoplasms;   Endocrine Gland Neoplasms;   Neoplasms by Site;   Neoplasms;   Ovarian Diseases;   Adnexal Diseases;   Genital Diseases, Female
Interventions: Drug: Trabectedin;   Drug: Dexamethasone
30 Withdrawn N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer
Conditions: Ovarian Carcinoma, Stage 3 or 4;   Epithelial Ovarian Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Drug: Paclitaxel;   Drug: N-acetylcysteine;   Drug: Cisplatin
31 Recruiting Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines
Conditions: Cancer of Ovary;   Cancer of the Ovary;   Neoplasms, Ovarian;   Ovarian Cancer;   Ovary Cancer;   Ovary Neoplasms
Interventions: Biological: Cisplatin + celecoxib + DC vaccine;   Biological: Cisplatin + CKM + Celecoxib + DC Vaccine
32 Completed Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: OSI-211 (Liposomal Lurtotecan)
33 Active, not recruiting [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer
Condition: Ovarian Neoplasm
Intervention: Drug: Pazopanib and paclitaxel
34 Completed 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients
Conditions: Ovarian Neoplasms;   Ovarian Diseases;   Adnexal Diseases;   Pancreatic Neoplasms;   Digestive System Neoplasms;   Digestive System Diseases;   Pancreatic Diseases
Intervention: Drug: 89Zr-MMOT0530A
35 Terminated Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Conditions: Neoplasms;   Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Primary Peritoneal Neoplasm
Interventions: Biological: KHK2866;   Drug: Gemcitabine and Carboplatin;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin
36 Completed A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer
Condition: Ovarian Neoplasm
Interventions: Drug: Cyclophosphamide;   Drug: Paclitaxel;   Drug: Cisplatin;   Drug: G-CSF
37 Recruiting STELLA 2 Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer
Conditions: Endometrial Neoplasms;   Ovarian Neoplasms
Interventions: Procedure: Extraperitoneal Laparoscopic aortic lymphadenectomy;   Procedure: Transperitoneal Laparoscopic aortic lymphadenectomy
38 Completed A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)
Condition: Ovarian Neoplasm
Intervention:
39 Completed Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma
Conditions: Genital Diseases, Female;   Ovarian Diseases;   Ovarian Neoplasms;   Endometrial Neoplasms
Intervention: Drug: Temsirolimus
40 Terminated CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy
Condition: Ovarian Neoplasms
Interventions: Drug: CAELYX;   Drug: Paclitaxel HCl

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years